What is the reason behind the increase in drug prescriptions prior to a dementia diagnosis?

Consider a scenario where a seemingly healthy individual in their late 50s, without any signs of dementia, is only on a few medications for precautionary reasons. However, as time passes, their memory starts to decline, focus wavers, and eventually, they receive a life-changing diagnosis. What if the early indicators were not in their actions but hidden in the medicines they were taking? Recent studies propose that the gradual accumulation of medications over time, especially certain types, could be subtly hinting at crucial clues long before dementia becomes apparent.

Overview

• The Silent Epidemic of Polypharmacy: Around 25% of individuals over 40 are consuming five or more medications, a trend associated with increased hospitalizations, drug interactions, and potentially a higher risk of dementia.

• Identifying Concerning Medications: Certain drugs, like anticholinergics commonly prescribed for various conditions, have been strongly linked to cognitive decline and an elevated risk of dementia.

• Predictive Patterns of Issues: Using machine learning, a study revealed that polypharmacy patterns become more concentrated and alike in the years leading up to a dementia diagnosis, offering a potential tool for early detection or prevention.

Doctors Are Concerned About This Increasing Prescription Trend

About a quarter of people above 40 are taking five or more prescription medications. This multiple medication intake can result in drug interactions, adverse effects, more frequent medical visits, and even hospitalizations.

Of particular concern, studies indicate that this prescribing escalation heightens the risk of dementia. Could the pattern of multiple prescription drug usage in the period before a dementia diagnosis provide clues about the future?

The World Health Organization acknowledges polypharmacy as a significant challenge to tackle. Their objective is to halve severe, avoidable medication-related harm in the coming years. It's going to be a tough task.

Medications for Treatment and Prevention

Today, many drugs taken by individuals in middle age and beyond are not for treating illnesses but for preventing various conditions. These include statins, blood thinners, and blood pressure medications to prevent heart disease, further escalating the risk of physical harm.

Patients needing hospital care who are on multiple medications have a higher chance of readmission within three months post-discharge and more than double the risk of mortality. One specific type of drug raises concerns regarding dementia risk.

Risks Associated with Anticholinergic Drugs

Anticholinergic medications are utilized in the management of respiratory disorders, cardiovascular diseases, bladder issues, gastrointestinal problems, and other ailments, making them widely used. Examples range from Glycopyrrolate (Robinul) to Benadryl.

An analysis of 18 studies involving 124,286 participants published in 2015 revealed that drugs with anticholinergic effects increase the chances of cognitive impairment, falls, and overall mortality in older adults.

A significant study published later involving over 300,000 seniors strongly connected certain anticholinergics to future dementia. Yet, this class of drug is just one among many commonly prescribed to adults, particularly older individuals.

To comprehend how medication usage evolved in dementia patients, a research team from the University of Plymouth in England decided to study the prescription patterns in the years leading up to diagnosis.

Prevalence of Polypharmacy Prior to Diagnosis

Using machine learning techniques, the team identified clusters of polypharmacy - meaning the simultaneous use of three or more prescription drugs - in 33,451 patients eventually diagnosed with dementia. They analyzed the 20 years leading to the diagnoses, dividing it into four five-year periods. The findings were published in the journal Aging and Disease in October.

Their analysis demonstrated that as the dementia diagnosis approached, the percentage of patients taking three or more medications rose from 5.5% twenty years out to 82.16% less than five years from diagnosis.

The team also observed that medication usage patterns became increasingly similar as patients neared the diagnosis date. Medications shifted from being prescribed for various unrelated conditions to being targeted at specific medical issues.

For example, in the closest four-year period to dementia diagnosis, three clusters of polypharmacy were identified, two of which were substantial. Two-thirds of patients were taking drugs for respiratory and urinary infections, arthritic and rheumatic conditions, and cardiovascular disease. A quarter were taking medications for infections, arthritic and rheumatic conditions, cardio-metabolic disease, and depression.

Exacerbating Symptoms of Illness

Most concerning, among all three polypharmacy clusters, the researchers found medications known to interact negatively with each other or worsen symptoms of other chronic conditions.

Since the study focused solely on dementia patients, it's unclear whether the prescription pattern can predict dementia.

Nonetheless, the researchers hope that recognizing patterns before diagnosis will provide insights into the effects of polypharmacy on dementia development, early intervention opportunities in prescribing, and identification of medications prone to drug-drug interactions.

Summary

There is a rising number of middle-aged and older adults taking multiple prescriptions, often five or more, for both treatment and prevention. This practice, known as polypharmacy, has been associated with significant risks, including increased hospital visits and possibly dementia. Research indicates a noticeable increase in medication use leading up to a dementia diagnosis, particularly drugs with adverse interactions or symptom aggravation. One particular class — anticholinergic medications — is notably linked to cognitive decline. While the study doesn't establish causation, it offers a fresh perspective to potentially identify dementia risk through prescription patterns.

Frequently Asked Questions

What is polypharmacy?

Polypharmacy refers to the use of multiple prescription medications, typically defined as consuming five or more, often observed in older adults.

How can polypharmacy increase dementia risk?

Specific medications, notably anticholinergic drugs, are known to hinder cognitive function and could contribute to or hasten dementia symptoms over time.

Are all medications equally risky in terms of cognitive decline?

No, anticholinergic medications show the strongest association with an increased risk of dementia, but overall drug interactions and combinations also play a vital role.

Can reducing medications help lower dementia risk?

Deprescribing — cautiously reducing unnecessary medications — may be beneficial, but it should always be done under the guidance of a healthcare professional.

What should I do if I'm concerned about the number of medications I take?

Discuss your current prescriptions with your doctor or pharmacist. A thorough medication review can help identify unnecessary or potentially harmful drugs.